ALTER — Theradiag SA Cashflow Statement
0.000.00%
- €16.44m
- €12.36m
- €12.20m
Annual cashflow statement for Theradiag SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.96 | -2.97 | -2.08 | -5.96 | -0.787 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.087 | -0.488 | -0.623 | 0.017 | -0.76 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.003 | -0.134 | -0.39 | 1.1 | -0.608 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.51 | -3.03 | -2.44 | -2.24 | -1.39 |
| Capital Expenditures | -1.01 | -0.547 | -0.276 | -0.351 | -0.154 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.054 | 0.287 | 0.109 | 0.238 | -0.002 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.96 | -0.26 | -0.167 | -0.113 | -0.156 |
| Financing Cash Flow Items | 0.91 | 1.88 | 1.68 | 0.767 | -0.073 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.74 | 3.54 | 2.82 | 3.77 | -0.181 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.735 | 0.252 | 0.211 | 1.42 | -1.73 |